CME Group (NASDAQ:CME) Price Target Raised to $295.00 at Royal Bank Of Canada

CME Group (NASDAQ:CME) had its price objective hoisted by equities research analysts at Royal Bank Of Canada from $282.00 to $295.00 in a research note issued to investors on Friday,MarketScreener reports. The brokerage presently has a “sector perform” rating on the financial services provider’s stock. Royal Bank Of Canada’s price objective suggests a potential upside of 7.98% from the company’s previous close.

Other equities research analysts have also recently issued research reports about the company. Keefe, Bruyette & Woods raised their price objective on CME Group from $283.00 to $287.00 and gave the stock a “market perform” rating in a report on Monday, October 13th. Deutsche Bank Aktiengesellschaft increased their target price on CME Group from $300.00 to $310.00 and gave the stock a “buy” rating in a research report on Friday, November 14th. TD Cowen lifted their price target on CME Group from $288.00 to $290.00 and gave the company a “hold” rating in a report on Thursday, October 23rd. Piper Sandler increased their price objective on shares of CME Group from $296.00 to $313.00 and gave the stock an “overweight” rating in a report on Thursday, November 13th. Finally, Citigroup upgraded shares of CME Group from a “neutral” rating to a “buy” rating and boosted their target price for the company from $275.00 to $300.00 in a report on Thursday, September 25th. Eight investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $289.18.

CME Group Stock Performance

NASDAQ:CME opened at $273.19 on Friday. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. The firm has a market cap of $98.51 billion, a PE ratio of 26.47, a P/E/G ratio of 4.28 and a beta of 0.28. The firm has a 50 day simple moving average of $271.55 and a 200-day simple moving average of $272.85. CME Group has a 1-year low of $224.62 and a 1-year high of $290.79.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.63 by $0.05. The firm had revenue of $1.54 billion for the quarter, compared to analyst estimates of $1.56 billion. CME Group had a net margin of 58.84% and a return on equity of 14.61%. CME Group’s revenue was down 3.0% compared to the same quarter last year. During the same quarter last year, the business earned $2.68 earnings per share. On average, equities analysts expect that CME Group will post 10.49 EPS for the current year.

Insider Buying and Selling

In other CME Group news, insider Timothy Francis Mccourt sold 379 shares of the business’s stock in a transaction dated Tuesday, September 16th. The stock was sold at an average price of $259.83, for a total transaction of $98,475.57. Following the transaction, the insider owned 9,508 shares in the company, valued at $2,470,463.64. The trade was a 3.83% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, General Counsel Jonathan L. Marcus sold 392 shares of the firm’s stock in a transaction dated Thursday, September 18th. The shares were sold at an average price of $262.00, for a total value of $102,704.00. Following the sale, the general counsel owned 7,851 shares in the company, valued at approximately $2,056,962. The trade was a 4.76% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 2,147 shares of company stock valued at $562,079. 0.30% of the stock is owned by company insiders.

Institutional Investors Weigh In On CME Group

Large investors have recently added to or reduced their stakes in the company. Atria Wealth Solutions Inc. lifted its position in shares of CME Group by 40.5% in the 1st quarter. Atria Wealth Solutions Inc. now owns 6,060 shares of the financial services provider’s stock worth $1,608,000 after buying an additional 1,746 shares during the last quarter. Citizens Financial Group Inc. RI raised its stake in shares of CME Group by 8.0% in the 1st quarter. Citizens Financial Group Inc. RI now owns 2,625 shares of the financial services provider’s stock worth $696,000 after buying an additional 194 shares in the last quarter. ASR Vermogensbeheer N.V. acquired a new stake in shares of CME Group in the first quarter valued at $5,289,000. Charles Schwab Investment Management Inc. boosted its stake in CME Group by 1.6% during the first quarter. Charles Schwab Investment Management Inc. now owns 2,081,023 shares of the financial services provider’s stock valued at $552,075,000 after buying an additional 33,336 shares in the last quarter. Finally, Deutsche Bank AG grew its holdings in CME Group by 5.3% during the first quarter. Deutsche Bank AG now owns 1,413,361 shares of the financial services provider’s stock worth $374,951,000 after acquiring an additional 71,444 shares during the period. 87.75% of the stock is owned by institutional investors and hedge funds.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.